Healthcare provider profile · identity verified

Erik Baker, MD

Internal Medicine · OKATIE, SC · NPI 1225071673

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	485	149
Amlodipine Besylate	Amlodipine Besylate	364	104
Levothyroxine Sodium	Levothyroxine Sodium	362	102
Losartan Potassium	Losartan Potassium	289	93
Omeprazole	Omeprazole	258	77
Pravastatin Sodium	Pravastatin Sodium	255	76
Gabapentin	Gabapentin	238	70
Lisinopril	Lisinopril	237	79
Metoprolol Succinate	Metoprolol Succinate	194	56
Metformin Hcl	Metformin Hcl	183	57
Rosuvastatin Calcium	Rosuvastatin Calcium	174	54
Hydrochlorothiazide	Hydrochlorothiazide	169	54
Tamsulosin Hcl	Tamsulosin Hcl	166	54
Furosemide	Furosemide	108	33
Metformin Hcl Er	Metformin Hcl	103	35
Potassium Chloride	Potassium Chloride	103	32
Simvastatin	Simvastatin	102	27
Allopurinol	Allopurinol	99	29
Tramadol Hcl	Tramadol Hcl	99	25
Pantoprazole Sodium	Pantoprazole Sodium	96	34
Sertraline Hcl	Sertraline Hcl	95	27
Albuterol Sulfate Hfa	Albuterol Sulfate	92	33
Eliquis	Apixaban	91	22
Trulicity	Dulaglutide	90	14
Ezetimibe	Ezetimibe	85	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	83	21
Trazodone Hcl	Trazodone Hcl	82	26
Carvedilol	Carvedilol	81	26
Famotidine	Famotidine	78	25
Metoprolol Tartrate	Metoprolol Tartrate	77	24
Jardiance	Empagliflozin	74	17
Bupropion Xl	Bupropion Hcl	72	18
Escitalopram Oxalate	Escitalopram Oxalate	72	22
Mounjaro	Tirzepatide	69	suppressed
Finasteride	Finasteride	67	17
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	66	15
Zolpidem Tartrate	Zolpidem Tartrate	65	16
Fluoxetine Hcl	Fluoxetine Hcl	62	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	62	12
Tizanidine Hcl	Tizanidine Hcl	61	20
Citalopram Hbr	Citalopram Hydrobromide	60	17
Glimepiride	Glimepiride	60	18
Montelukast Sodium	Montelukast Sodium	60	20
Clopidogrel	Clopidogrel Bisulfate	56	19
Duloxetine Hcl	Duloxetine Hcl	54	19
Lorazepam	Lorazepam	53	11
Alprazolam	Alprazolam	52	14
Paroxetine Hcl	Paroxetine Hcl	51	11
Atenolol	Atenolol	50	15
Olmesartan Medoxomil	Olmesartan Medoxomil	50	11
Valsartan	Valsartan	50	15
Fluticasone Propionate	Fluticasone Propionate	48	18
Meloxicam	Meloxicam	46	14
Mirtazapine	Mirtazapine	42	13
Diclofenac Sodium	Diclofenac Sodium	41	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	12
Spironolactone	Spironolactone	41	14
Esomeprazole Magnesium	Esomeprazole Magnesium	38	11
Hydroxyzine Hcl	Hydroxyzine Hcl	38	16
Ozempic	Semaglutide	38	suppressed
Pregabalin	Pregabalin	38	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	36	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	35	31
Prednisone	Prednisone	34	24
Doxycycline Hyclate	Doxycycline Hyclate	32	27
Venlafaxine Hcl Er	Venlafaxine Hcl	32	suppressed
Celecoxib	Celecoxib	30	13
Lansoprazole	Lansoprazole	30	suppressed
Methylprednisolone	Methylprednisolone	29	23
Clonazepam	Clonazepam	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Glipizide Er	Glipizide	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	13
Azithromycin	Azithromycin	24	23
Buspirone Hcl	Buspirone Hcl	24	suppressed
Donepezil Hcl	Donepezil Hcl	24	suppressed
Naproxen	Naproxen	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	15
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Ibandronate Sodium	Ibandronate Sodium	23	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Glipizide	Glipizide	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	20	suppressed
Klor-Con M20	Potassium Chloride	19	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	18	suppressed
Irbesartan	Irbesartan	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Estradiol	Estradiol	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Colestipol Hcl	Colestipol Hcl	16	suppressed
Mupirocin	Mupirocin	16	suppressed
Temazepam	Temazepam	16	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Nystatin	Nystatin	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Sildenafil Citrate	Sildenafil Citrate	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	14	suppressed
Linzess	Linaclotide	14	suppressed
Lipitor	Atorvastatin Calcium	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Ramipril	Ramipril	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Fluconazole	Fluconazole	13	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Perindopril Erbumine	Perindopril Erbumine	13	suppressed
Alendronate Sodium	Alendronate Sodium	12	suppressed
Baclofen	Baclofen	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Propranolol Hcl	Propranolol Hcl	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Bydureon Bcise	Exenatide Microspheres	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Icosapent Ethyl	Icosapent Ethyl	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error